Add like
Add dislike
Add to saved papers

Investigation of the susceptibility of Candida auris and Candida albicans to chemical disinfectants using the European Standards EN 13624 and EN 16615.

BACKGROUND: Since the first appearance of Candida auris in 2009, this yeast species has become a relevant pathogen in the clinical field. C. auris has been detected on various surfaces in health facilities, thus being a target for appropriate disinfection procedures. Preventive measures have to be implemented based on disinfectants with proven efficacy against C. auris.

AIM: The chemical tolerance of C. auris was compared with the surrogate test organism Candida albicans as established in the European standards (EN). In this way, conclusions will be drawn as to whether the disinfectants tested according to EN 13624 and EN 16615 are at least equally effective against C. auris.

METHODS: The chemical susceptibility of C. auris and C. albicans was investigated using standardized EN test protocols. EN 13624 and EN 16615 were used in this study examining two commercially available surface disinfectants based on alcohol or quaternary ammonium compounds (QACs), respectively. In addition, the survival rates of the two yeast species were studied on a defined test surface simulating practical conditions.

FINDINGS: When compared to C. albicans C. auris was found to be significantly more susceptible to the tested alcohol-based and the QAC-based disinfectant. C. albicans was found to be more tolerant to drying on the test surface in the quantitative carrier test EN 16615, yielding higher recovery rates.

CONCLUSION: C. albicans is a suitable surrogate test organism when targeting yeasticidal efficacy, which, based on EN 13624 and EN 16615, includes efficacy against the human pathogen C. auris.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app